xdesign—it continues to lack access to clinically validated, human-relevant biological data.
Qureator fills this critical need. By combining physiologically relevant 3D disease models with scalable data generation, the platform bridges the divide between computational discovery and translational impact. Dr. Baek emphasized that Qureator is the “missing piece” enabling AI to drive meaningful advances in real-world patient outcomes.
Special thanks to Joe McClung for leading the session and sparking powerful conversations about the future of precision therapeutics.
https://www.linkedin.com/feed/update/urn:li:activity:7308681419197751296